Bio Green Med Solution (BGMS) Total Liabilities (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Total Liabilities of $804000.0 for Q1 2026, up 19.64% year-over-year from $672000.0 in Q1 2025, and down 40.13% quarter-over-quarter from $1.3 million in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Total Liabilities (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Total Liabilities for 17 consecutive years, with $804000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities rose 19.64% year-over-year to $804000.0; the TTM figure through Mar 2026 stood at $804000.0 (up 19.64% YoY), while the FY2025 annual figure was $1.3 million, down 78.57% from the prior year.
- Total Liabilities fell to $804000.0 in Q1 2026 per BGMS's latest filing, from $1.3 million in the prior quarter.
- Across five years, Total Liabilities topped out at $8.4 million in Q1 2024 and bottomed at $672000.0 in Q1 2025.
- Historically, Total Liabilities has averaged $5.1 million across 5 years, with a median of $6.3 million in 2022.
- Annual changes were most pronounced in 2023 — Total Liabilities jumped 79.08% — and 2025, when it tumbled 91.97%.
- Bio Green Med Solution's Total Liabilities stood at $7.6 million in 2022, then advanced by 7.63% to $8.2 million in 2023, then decreased by 23.54% to $6.3 million in 2024, then plunged by 78.57% to $1.3 million in 2025, then slumped by 40.13% to $804000.0 in 2026.
- Business Quant data shows BGMS's Total Liabilities at $804000.0 in Q1 2026, $1.3 million in Q4 2025, and $1.1 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.38 Bn | 133.52 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 65.05 Bn | 59.87 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 57.47 Bn | 52.34 Bn | 52.00 Mn | 4.20 Bn |
| 5 | Revolution Medicines | 44.67 Bn | 44.67 Bn | - | 1.72 Bn |
| 6 | BeOne Medicines | 40.40 Bn | 35.31 Bn | 1.53 Bn | 4.00 Bn |
| 7 | Alnylam Pharmaceuticals | 35.37 Bn | 32.06 Bn | 992.69 Mn | 4.20 Bn |
| 8 | Royalty Pharma | 28.15 Bn | 27.31 Bn | - | 10.03 Bn |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | 1.35 Bn |
| 10 | Bio Green Med Solution | 4.87 Mn | 1.08 Mn | 79,000.00 | 694,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 694,000.00 |
| Mar 31, 2026 | 804,000.00 |
| Dec 31, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 770,000.00 |
| Mar 31, 2025 | 672,000.00 |
| Dec 31, 2024 | 6.27 Mn |
| Sep 30, 2024 | 6.35 Mn |
| Jun 30, 2024 | 7.19 Mn |
| Mar 31, 2024 | 8.37 Mn |
| Dec 31, 2023 | 8.20 Mn |
| Sep 30, 2023 | 8.20 Mn |
| Jun 30, 2023 | 6.93 Mn |
| Mar 31, 2023 | 7.54 Mn |
| Dec 31, 2022 | 7.62 Mn |
| Sep 30, 2022 | 4.58 Mn |
| Jun 30, 2022 | 5.26 Mn |
| Mar 31, 2022 | 6.34 Mn |
| Dec 31, 2021 | 5.44 Mn |
| Sep 30, 2021 | 3.70 Mn |